Pregnanetriol
![]()  | |
| Names | |
|---|---|
| IUPAC name
 (20S)-5β-Pregnane-3α,17,20-triol  | |
| Systematic IUPAC name
 (1R,3aS,3bR,5aR,7R,9aS,9bS,11aS)-1-[(1S)-1-Hydroxyethyl]-9a,11a-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-1,7-diol  | |
| Other names
 5β-Pregnane-3α,17α,20α-triol  | |
| Identifiers | |
CAS Number  | 
|
3D model (JSmol)  | 
|
| ChemSpider | |
| ECHA InfoCard | 100.012.862 | 
PubChem CID  | 
|
| UNII | |
CompTox Dashboard (EPA)  | 
|
InChI 
  | |
SMILES 
  | |
| Properties | |
Chemical formula  | 
C21H36O3 | 
| Molar mass | 336.516 g·mol−1 | 
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). 
Infobox references  | |
Pregnanetriol, or 5β-pregnane-3α,17α,20α-triol, is a steroid and inactive metabolite of progesterone.
Urine testing
Urine excretion of pregnanetriol can be measured over a period of 24 hours. Elevated urine pregnanetriol levels suggest adrenogenital syndrome. In monitoring treatment with cortisol replacement, elevated urine pregnanetriol levels indicate insufficient dosage of cortisol.[1]
Reference ranges
For females:[1]
- 0 to 5 years: < 0.1 mg/24 hours
 - 6 to 9 years: < 0.3 mg/24 hours
 - 10 to 15 years: 0.1 to 0.6 mg/24 hours
 - 16 years and older: 0 to 1.4 mg/ 24 hours.
 
For males:[1]
- 0 to 5 years: < 0.1 mg/24 hours
 - 6 to 9 years: < 0.3 mg/24 hours
 - 10 to 15 years: 0.2 to 0.6 mg/24 hours
 - 16 years and older: 0.2 to 2 mg/ 24 hours
 
See also
Pregnanetriolone
References
- 1 2 3 online-family-doctor.com Pregnanetriol Retrieved April 2011
 
    This article is issued from Wmcloud. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
